SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mark Buczynski who wrote (12768)4/7/2014 12:16:41 PM
From: boomertree2  Respond to of 13111
 
I merely copied and pasted the articles that came to me in my daily FDA reporting service. I don't see how anyone could get the wrong impression from the articles since they almost exclusively addressed the Amgen drug's failure to meet survival endpoints and highlighted the drugs material side effects.